Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
October 10, 2025
Biotechnology
-
-
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
October 10, 2025
-
Spruce Biosciences Announces $50.0 Million Private Placement Financing
October 8, 2025
-
Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
October 8, 2025
-
Trevi Therapeutics Announces Oral Presentation and Abstracts at CHEST 2025 Annual Meeting
October 8, 2025
-
Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)
October 6, 2025
-
Theratechnologies Announces Completion of Acquisition by Future Pak
September 25, 2025
-
Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings
September 25, 2025
-
Renalytix: Transforming Diabetes and Kidney Disease Through Early Risk Prediction
September 12, 2025
-
Biofrontera Inc.: A Compelling Investment in Dermatology
September 9, 2025
-
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
August 18, 2025
-
FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet’s Disease after Reviewing Recent Phase 2 Clinical Study Results
August 18, 2025
-
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic
August 11, 2025
-
Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio(TM) Initiative
August 11, 2025
-
Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment
August 7, 2025
-
Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy
August 7, 2025